Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Biontech Says European Patent Office's Decision To Maintain Moderna's Patent EP No. 3 590 949 B1 In Amended Form Does Not Change Co's Stance On Patent; Says "Believe That Neither Ep '949 Nor Any Of The Auxiliary Requests Filed By Moderna Meet The Requirements For Patentability"; Says "Will Continue To Vigorously Defend" Its Innovations Against All Allegations Of Patent Infringement Including EP '949 Case

Author: Benzinga Newsdesk | May 17, 2024 01:40pm

-Reuters

Posted In: BNTX